As the development of our psychotropics-based medicines progresses and the market expands into commercial-scale products, we are developing our business in consumer product manufacture, marketing, and distribution to create additional streams of revenue.
Our team is identifying and developing multiple nootropic and other non-regulated psychotropic products and formulations to impact health and wellness outside of medical application spaces.